Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
3.000
-0.050 (-1.64%)
Nov 21, 2024, 4:00 PM EST - Market closed

Vigil Neuroscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-82.6-82.64-68.31-43.28-57.09
Depreciation & Amortization
0.450.40.080.03-
Asset Writedown & Restructuring Costs
----41.85
Loss (Gain) From Sale of Investments
-0.97-1.49---
Stock-Based Compensation
10.048.95.482.090.52
Other Operating Activities
1.391.360.931.182.66
Change in Accounts Payable
-0.440.01-2.482.352.21
Change in Other Net Operating Assets
3.523.09-0.85-1.71-0.51
Operating Cash Flow
-48.59-70.36-65.15-39.35-10.36
Capital Expenditures
-0.02-0.67-0.92-0.2-
Sale (Purchase) of Intangibles
-----1
Investment in Securities
11.61-64.46---
Investing Cash Flow
11.59-65.14-0.92-0.2-1
Total Debt Issued
----10
Long-Term Debt Repaid
--0.02-0.04-0.04-
Net Debt Issued (Repaid)
--0.02-0.04-0.0410
Issuance of Common Stock
5.30.91140.620.040
Other Financing Activities
--20.68-1.89-
Financing Cash Flow
25.110.89161.26107.7559.66
Net Cash Flow
-11.9-134.6195.1968.248.3
Free Cash Flow
-48.61-71.04-66.07-39.55-10.36
Free Cash Flow Per Share
-1.22-1.84-2.09-25.82-7.68
Levered Free Cash Flow
-20.72-40.06-41.43-22.5-
Unlevered Free Cash Flow
-20.72-40.06-41.43-22.5-
Change in Net Working Capital
-24.06-6.853.01-2.1-
Source: S&P Capital IQ. Standard template. Financial Sources.